Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 115 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24 | -20.0% | 4,483 | 0.0% | 0.00% | – |
| Q2 2023 | $30 | +20.0% | 4,483 | -11.2% | 0.00% | – |
| Q1 2023 | $25 | -10.7% | 5,049 | -13.2% | 0.00% | – |
| Q4 2022 | $28 | -100.0% | 5,819 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $84,000 | -3.4% | 5,819 | +1.6% | 0.00% | 0.0% |
| Q2 2022 | $87,000 | +27.9% | 5,727 | +0.4% | 0.00% | 0.0% |
| Q1 2022 | $68,000 | -69.5% | 5,706 | -13.5% | 0.00% | -50.0% |
| Q2 2021 | $223,000 | -5.5% | 6,599 | +38.5% | 0.00% | -77.8% |
| Q4 2020 | $236,000 | +14.0% | 4,764 | -0.6% | 0.01% | -10.0% |
| Q2 2020 | $207,000 | – | 4,792 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $1,041,909 | 4.24% |
| Sofinnova Investments, Inc. | 2,194,278 | $11,958,815 | 0.75% |
| DENALI ADVISORS LLC | 85,900 | $468,155 | 0.16% |
| Polar Capital Holdings Plc | 2,103,298 | $11,462,974 | 0.08% |
| Soleus Capital Management, L.P. | 157,182 | $856,642 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 137,299 | $748 | 0.06% |
| Caligan Partners LP | 23,321 | $127,099 | 0.06% |
| Corton Capital Inc. | 12,244 | $66,730 | 0.03% |
| RICE HALL JAMES & ASSOCIATES, LLC | 91,249 | $497,307 | 0.03% |
| CIM INVESTMENT MANAGEMENT INC | 15,313 | $83,456 | 0.03% |